High-rolling investors have positioned themselves bullish on Madrigal Pharmaceuticals (NASDAQ:MDGL), and it's important for retail traders to take note. \This activity came to our attention today ...
Explore Madrigal Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDGL. Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing ...
BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 and keeps an Underperform rating on the shares. The Q4 updates, which included “favorable” two-year OLE data, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback